Performance of Surface Immobilized RGDC 13–93 Bioactive Glass Fiber Rafts and Scaffolds with MLO-A5 Osteogenic Cells In Vitro
- Vernon Modglin
- Roger Brown
Abstract
The aim of this study was to evaluate the ability of 13–93 bioactive glass constructs with surface immobilized peptide Arg-Gly-Asp-Cys (RGDC) to support the growth and differentiation of mouse MLO-A5 cells, an established osteogenic cell line. The construct types tested included 13–93 glass fiber rafts and fiber scaffolds possessing a surface with covalently bonded RGDC and seeded with MLO-A5 cells cultured for intervals up to 5 days. The RGDC treated rafts showed about a 3-fold higher cell attachment and about an 8-fold higher cell growth compared to control rafts. The RGDC treated scaffolds had an estimated 2-fold higher cell abundance than untreated control scaffolds. Protein measurements indicated a 1.6-fold higher level of cell growth on the RGDC coated scaffolds compared to controls during the incubation. Alkaline phosphatase activity, a key marker of osteoblast differentiation, was 2.3-fold higher at day 5 on RGDC scaffolds compared to controls. Collectively, the results indicate that the 13–93 glass fiber rafts and scaffolds with immobilized RGDC enhance the attachment, growth, and differentiation of MLO-A5 osteogenic cells and that bioactive glass scaffolds with biomimetic surfaces could potentially be effective for enhanced bone tissue engineering applications.
Journal Metrics
The data was calculated based on Google Scholar Citations
Google-based Impact Factor (2021): 0.52
h-index (December 2021): 22
i10-index (December 2021): 74
h5-index (December 2021): N/A
h5-median (December 2021): N/A
Index
Contact
- John MartinEditorial Assistant
- jmsr@ccsenet.org